156 related articles for article (PubMed ID: 38488902)
21. Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast Cancer Res Treat; 2023 Jul; 200(1):37-45. PubMed ID: 37138198
[TBL] [Abstract][Full Text] [Related]
22. Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Kroeze SGC; Pavic M; Stellamans K; Lievens Y; Becherini C; Scorsetti M; Alongi F; Ricardi U; Jereczek-Fossa BA; Westhoff P; But-Hadzic J; Widder J; Geets X; Bral S; Lambrecht M; Billiet C; Sirak I; Ramella S; Giovanni Battista I; Benavente S; Zapatero A; Romero F; Zilli T; Khanfir K; Hemmatazad H; de Bari B; Klass DN; Adnan S; Peulen H; Salinas Ramos J; Strijbos M; Popat S; Ost P; Guckenberger M
Lancet Oncol; 2023 Mar; 24(3):e121-e132. PubMed ID: 36858728
[TBL] [Abstract][Full Text] [Related]
23. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Hurvitz SA; Hegg R; Chung WP; Im SA; Jacot W; Ganju V; Chiu JWY; Xu B; Hamilton E; Madhusudan S; Iwata H; Altintas S; Henning JW; Curigliano G; Perez-Garcia JM; Kim SB; Petry V; Huang CS; Li W; Frenel JS; Antolin S; Yeo W; Bianchini G; Loi S; Tsurutani J; Egorov A; Liu Y; Cathcart J; Ashfaque S; Cortés J
Lancet; 2023 Jan; 401(10371):105-117. PubMed ID: 36495879
[TBL] [Abstract][Full Text] [Related]
24. Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial.
Lin NU; Murthy RK; Abramson V; Anders C; Bachelot T; Bedard PL; Borges V; Cameron D; Carey LA; Chien AJ; Curigliano G; DiGiovanna MP; Gelmon K; Hortobagyi G; Hurvitz SA; Krop I; Loi S; Loibl S; Mueller V; Oliveira M; Paplomata E; Pegram M; Slamon D; Zelnak A; Ramos J; Feng W; Winer E
JAMA Oncol; 2023 Feb; 9(2):197-205. PubMed ID: 36454580
[TBL] [Abstract][Full Text] [Related]
25. Preoperative stereotactic radiosurgery in the management of brain metastases and gliomas.
Lehrer EJ; Kowalchuk RO; Ruiz-Garcia H; Merrell KW; Brown PD; Palmer JD; Burri SH; Sheehan JP; Quninoes-Hinojosa A; Trifiletti DM
Front Surg; 2022; 9():972727. PubMed ID: 36353610
[TBL] [Abstract][Full Text] [Related]
26. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Palmer JD; Klamer BG; Ballman KV; Brown PD; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
JAMA Oncol; 2022 Dec; 8(12):1809-1815. PubMed ID: 36264568
[TBL] [Abstract][Full Text] [Related]
27. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
Bernhardt D; König L; Grosu A; Wiestler B; Rieken S; Wick W; Gempt J; Krieg SM; Schmidt-Graf F; Sahm F; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
Strahlenther Onkol; 2022 Oct; 198(10):873-883. PubMed ID: 36038669
[TBL] [Abstract][Full Text] [Related]
28. A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Kumthekar PU; Avram MJ; Lassman AB; Lin NU; Lee E; Grimm SA; Schwartz M; Bell Burdett KL; Lukas RV; Dixit K; Perron I; Zhang H; Gradishar WJ; Pentsova EI; Jeyapalan S; Groves MD; Melisko M; Raizer JJ
Neuro Oncol; 2023 Mar; 25(3):557-565. PubMed ID: 35948282
[TBL] [Abstract][Full Text] [Related]
29. Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial.
Bartsch R; Berghoff AS; Furtner J; Marhold M; Bergen ES; Roider-Schur S; Starzer AM; Forstner H; Rottenmanner B; Dieckmann K; Bago-Horvath Z; Haslacher H; Widhalm G; Ilhan-Mutlu A; Minichsdorfer C; Fuereder T; Szekeres T; Oehler L; Gruenberger B; Singer CF; Weltermann A; Puhr R; Preusser M
Nat Med; 2022 Sep; 28(9):1840-1847. PubMed ID: 35941372
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
Oberkampf F; Gutierrez M; Trabelsi Grati O; Le Rhun É; Trédan O; Turbiez I; Kadi A; Dubot C; Taillibert S; Vacher S; Bonneau C
Neuro Oncol; 2023 Feb; 25(2):365-374. PubMed ID: 35868630
[TBL] [Abstract][Full Text] [Related]
31. Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.
Yang JT; Wijetunga NA; Pentsova E; Wolden S; Young RJ; Correa D; Zhang Z; Zheng J; Steckler A; Bucwinska W; Bernstein A; Betof Warner A; Yu H; Kris MG; Seidman AD; Wilcox JA; Malani R; Lin A; DeAngelis LM; Lee NY; Powell SN; Boire A
J Clin Oncol; 2022 Nov; 40(33):3858-3867. PubMed ID: 35802849
[TBL] [Abstract][Full Text] [Related]
32. Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside.
Meattini I; Livi L; Lorito N; Becherini C; Bacci M; Visani L; Fozza A; Belgioia L; Loi M; Mangoni M; Lambertini M; Morandi A
Cancer Treat Rev; 2022 Jul; 108():102417. PubMed ID: 35623219
[TBL] [Abstract][Full Text] [Related]
33. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
Gondi V; Bauman G; Bradfield L; Burri SH; Cabrera AR; Cunningham DA; Eaton BR; Hattangadi-Gluth JA; Kim MM; Kotecha R; Kraemer L; Li J; Nagpal S; Rusthoven CG; Suh JH; Tomé WA; Wang TJC; Zimmer AS; Ziu M; Brown PD
Pract Radiat Oncol; 2022; 12(4):265-282. PubMed ID: 35534352
[TBL] [Abstract][Full Text] [Related]
34. PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
Barcellini A; Loap P; Murata K; Villa R; Kirova Y; Okonogi N; Orlandi E
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771545
[TBL] [Abstract][Full Text] [Related]
35. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
[TBL] [Abstract][Full Text] [Related]
36. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.
Le Rhun E; Guckenberger M; Smits M; Dummer R; Bachelot T; Sahm F; Galldiks N; de Azambuja E; Berghoff AS; Metellus P; Peters S; Hong YK; Winkler F; Schadendorf D; van den Bent M; Seoane J; Stahel R; Minniti G; Wesseling P; Weller M; Preusser M;
Ann Oncol; 2021 Nov; 32(11):1332-1347. PubMed ID: 34364998
[No Abstract] [Full Text] [Related]
37. Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer.
Suwinski R
J Thorac Dis; 2021 May; 13(5):3315-3322. PubMed ID: 34164224
[TBL] [Abstract][Full Text] [Related]
38. Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study.
Lin NU; Pegram M; Sahebjam S; Ibrahim N; Fung A; Cheng A; Nicholas A; Kirschbrown W; Kumthekar P
J Clin Oncol; 2021 Aug; 39(24):2667-2675. PubMed ID: 33945296
[TBL] [Abstract][Full Text] [Related]
39. A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases.
Hartgerink D; Bruynzeel A; Eekers D; Swinnen A; Hurkmans C; Wiggenraad R; Swaak-Kragten A; Dieleman E; van der Toorn PP; Oei B; van Veelen L; Verhoeff J; Lagerwaard F; de Ruysscher D; Lambin P; Zindler J
Neurooncol Adv; 2021; 3(1):vdab021. PubMed ID: 33738451
[TBL] [Abstract][Full Text] [Related]
40. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
